Plurify

Excited to reveal Plurify to the US during JPM week at Biotech Showcase, on January 15 @ 2:50pm. Reach out and let's meet up if you're in SF! Informa Connect

We’re growing our team in Cambridge. We’re on the lookout for entrepreneurial scientists who want to be part of something big. We’re hiring for two great roles at our new lab in the heart of Cambridge's research community: - Research Scientist - Research Assistant / Technician We’re a small team with big ideas looking for like minded people to join us on our journey to shape the future of stem cell therapies. Sound like you? Head to our website for full details and application links: https://lnkd.in/eMqtH-tR

We’re growing our team in Cambridge. We’re on the lookout for entrepreneurial scientists who want to be part of something big. We’re hiring for two great roles at our new lab in the heart of Cambridge's research community: - Research Scientist - Research Assistant / Technician We’re a small team with big ideas looking for like minded people to join us on our journey to shape the future of stem cell therapies. Sound like you? Head to our website for full details and application links: https://lnkd.in/eMqtH-tR

Plurify: Breaking down the barriers to universal stem cell therapies. 🌟 Meet Plurify, one of the latest additions to the Kadmos Capital Portfolio. Plurify is pioneering a future where advanced cell therapies are not only safer but also accessible to all. Their groundbreaking technology eliminates unwanted cell populations, addressing a critical bottleneck in cell therapy manufacturing. Learn more about their vision and innovation: https://www.plurify.bio/ Proud to support this transformative journey. 💡 #KadmosCapitalPortfolio #CellTherapy #Innovation #Biotech #HealthcareRevolution

If you want to know what we've been up to in the lab this year, get to Cell 2024 next Wednesday when our CEO Djordje will present our early data for the first time!

I’m very excited to be attending this weeks ISSCR conference with some of my old colleagues in Copenhagen and catching up on the world of pluripotent stem cell derived therapies. If you want to hear about the best new way to remove unwanted cells from your cell product - come and find me! 🤓

From £340k injected into cell therapy technologies, to new aviation developments, we’re really excited to share the latest updates from the #CatapultNetwork 💥 Cell and Gene Therapy Catapult and Plurify have joined forces to develop technology which improves purity of cell therapies. Having received over £340,000 funding from Innovate UK, the partnership seeks to make therapies safer, more effective, and less costly to produce 🧫 Compound Semiconductor Applications (CSA) Catapult hosted its first meet up for those working at the forefront of critical semiconductor technologies and applications within the UK. Meanwhile, Connected Places Catapult has selected five new businesses to develop aviation uses for digital twin technology ✈️ and Digital Catapult has welcomed a cohort of eight new companies to bolster UK cyber security 🔐 Energy Systems Catapult shared their latest ITES Knowledge Series webinar with Senior Policy Advisor, George Day, discussing a potential India-UK collaboration to support the country’s ambitious green hydrogen plans 💬 To find out more, check out our roundup video and follow the links below ⬇️ Cell and Gene Therapy Catapult – https://shorturl.at/OQ3nG Compound Semiconductor Applications (CSA) Catapult – https://shorturl.at/rq36b Connected Places Catapult – https://shorturl.at/UGlGS Digital Catapult – https://shorturl.at/7prIh Energy Systems Catapult – https://shorturl.at/1pd1t #Innovation #Investment #Sustainability #NetZero

Congratulations to new Ministers Wes Streeting and Peter Kyle. We look forward to the implementation of their ambitious Life Sciences Sector Plan, as well as further engagement with the new government around the promise and challenges of creating advanced stem cell therapies.

Did you see our recent announcement with Plurify on receiving over £340,000 funding from Innovate UK as part of the Transforming Medicines Manufacturing Programme. With this funding, Plurify and the CGT Catapult will develop and test a technology that removes residual cells from cell therapy products during their production, with the aim of making these therapies safer, more efficacious and less costly to produce. Learn more: https://lnkd.in/e3kFwEYA #CellTherapy #AdvancedTherapies #ATMPs #Collaboration #TransformingMedicinesManufacturing

We are very happy to share this news about an Innovate UK grant we won as part of the Transforming Medicines Manufacturing Programme. We are very grateful for the funding that helps to build up our core R&D programs and test them with the great team at CGT Catapult. Also a big thank you to the assessors who believed in what we are doing and provided the first external expert validation of our ideas. The research is underway and we look forward to sharing the results when we can! 👨🔬👨💻